Susan C Tilton

Dr. Susan C Tilton

Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2016 in BMC Systems Biology
Verified
Journal Article
Open access
PDF file
JMJason E. McDermott
Jason E. McDermott
HMHugh D. Mitchell
Hugh D. Mitchell
LGLisa Gralinski
Lisa Gralinski
AEAmie J. Eisfeld
Amie J. Eisfeld
LJLaurence Josset
Laurence Josset
KWKatrina M. Waters
Katrina M. Waters
The complex interplay between viral replication and host immune response during infection remains poorly understood. While many viruses are known to employ anti-immune strategies to facilitate their replication, highly pathogenic virus infections can also cause an excessive immune response that exacerbates, rather than reduces pathogenicity. To investigate this dichotomy in severe acute respiratory syndrome coronavirus (SARS-CoV), we developed a transcriptional network model of SARS-CoV infection in mice and used the model to prioritize candidate regulatory targets for further investigation. We validated our predictions in 18 different knockout (KO) mouse strains, showing that network topology provides significant predictive power to identify genes that are important for viral infection. We identified a novel player in the immune response to virus infection, Kepi, an inhibitory subunit of the protein phosphatase 1 (PP1) complex, which protects against SARS-CoV pathogenesis. We also found that receptors for the proinflammatory cytokine tumor necrosis factor alpha (TNFα) promote pathogenesis, presumably through excessive inflammation. The current study provides validation of network modeling approaches for identifying important players in virus infection pathogenesis, and a step forward in understanding the host response to an important infectious disease. The results presented here suggest the role of Kepi in the host response to SARS-CoV, as well as inflammatory activity driving pathogenesis through TNFα signaling in SARS-CoV infections. Though we have reported the utility of this approach in bacterial and cell culture studies previously, this is the first comprehensive study to confirm that network topology can be used to predict phenotypes in mice with experimental validation.

1 September 2019 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
YCYvonne Chang
Yvonne Chang
LSLisbeth K. Siddens
Lisbeth K. Siddens
LHLauren K. Heine
Lauren K. Heine
DSDavid A. Sampson
David A. Sampson
ZYZhen Yu
Zhen Yu
Susan C TiltonSusan C Tilton
Susan C Tilton

15 December 2021 in Environment International
Verified
Journal Article
Open access
MMMonica Maier
Monica Maier
LSLisbeth K. Siddens
Lisbeth K. Siddens
JPJamie M. Pennington
Jamie M. Pennington
SUSandra L. Uesugi
Sandra L. Uesugi
KAKim A. Anderson
Kim A. Anderson
DWDavid Williams
David Williams
Benzo[a]pyrene (BaP) is formed by incomplete combustion of organic materials (petroleum, coal, tobacco, etc.). BaP is designated by the International Agency for Research on Cancer as a group 1 known human carcinogen; a classification supported by numerous studies in preclinical models and epidemiology studies of exposed populations. Risk assessment relies on toxicokinetic and cancer studies in rodents at doses 5–6 orders of magnitude greater than average human uptake. Using a dose-response design at environmentally relevant concentrations, this study follows uptake, metabolism, and elimination of [14C]-BaP in human plasma by employing UPLC - accelerator mass spectrometry (UPLC-AMS). Volunteers were administered 25, 50, 100, and 250 ng (2.7–27 nCi) of [14C]-BaP (with interceding minimum 3-week washout periods) with quantification of parent [14C]-BaP and metabolites in plasma measured over 48 hours. [14C]-BaP median Tmax was 30 minutes with Cmax and area under the curve (AUC) approximating dose-dependency. Marked inter-individual variability in plasma pharmacokinetics following a 250 ng dose was seen with 7 volunteers as measured by the Cmax (8.99 ± 7.08 ng × mL−1) and AUC0–48hr (68.6 ± 64.0 fg × hr−1 × mL−1). Approximately 3–6% of the [14C] recovered (AUC0–48 hr) was parent compound, demonstrating extensive metabolism following oral dosing. Metabolite profiles showed that, even at the earliest time-point (30 min), a substantial percentage of [14C] in plasma was polar BaP metabolites. The best fit modeling approach identified non-compartmental apparent volume of distribution of BaP as significantly increasing as a function of dose (p=0.004). Bay region tetrols and dihydrodiols predominated, suggesting not only was there extensive first pass metabolism but also potentially bioactivation. AMS enables the study of environmental carcinogens in humans with de minimus risk, allowing for important testing and validation of physiologically based pharmacokinetic models derived from animal data, risk assessment, and the interpretation of data from high-risk occupationally exposed populations.

22 April 2015 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
Susan C TiltonSusan C Tilton
Susan C Tilton
LSLisbeth K. Siddens
Lisbeth K. Siddens
SKSharon K. Krueger
Sharon K. Krueger
ALAndrew J. Larkin
Andrew J. Larkin
CLChristiane V. Löhr
Christiane V. Löhr
KWKatrina M. Waters
Katrina M. Waters
We have previously shown that relative potency factors and DNA adduct measurements are inadequate for predicting carcinogenicity of certain polycyclic aromatic hydrocarbons (PAHs) and PAH mixtures, particularly those that function through alternate pathways or exhibit greater promotional activity compared to benzo[a]pyrene (BaP). Therefore, we developed a pathway-based approach for classification of tumor outcome after dermal exposure to PAH/mixtures. FVB/N mice were exposed to dibenzo[def,p]chrysene (DBC), BaP, or environmental PAH mixtures (Mix 1-3) following a 2-stage initiation/promotion skin tumor protocol. Resulting tumor incidence could be categorized by carcinogenic potency as DBC >> BaP = Mix2 = Mix3 > Mix1 = Control, based on statistical significance. Gene expression profiles measured in skin of mice collected 12 h post-initiation were compared with tumor outcome for identification of short-term bioactivity profiles. A Bayesian integration model was utilized to identify biological pathways predictive of PAH carcinogenic potential during initiation. Integration of probability matrices from four enriched pathways (P < .05) for DNA damage, apoptosis, response to chemical stimulus, and interferon gamma signaling resulted in the highest classification accuracy with leave-one-out cross validation. This pathway-driven approach was successfully utilized to distinguish early regulatory events during initiation prognostic for tumor outcome and provides proof-of-concept for using short-term initiation studies to classify carcinogenic potential of environmental PAH mixtures. These data further provide a ‘source-to-outcome’ model that could be used to predict PAH interactions during tumorigenesis and provide an example of how mode-of-action-based risk assessment could be employed for environmental PAH mixtures.

1 August 2017 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
LCLawrence R. Curtis
Lawrence R. Curtis
CBClaudia F. Bravo
Claudia F. Bravo
CBChristopher J. Bayne
Christopher J. Bayne
FTFred Tilton
Fred Tilton
MAMary R. Arkoosh
Mary R. Arkoosh
Susan C TiltonSusan C Tilton
Susan C Tilton

2 September 2020 in Toxicology in Vitro
Verified
Journal Article
Closed access
YCYvonne Chang
Yvonne Chang
CHCeline Thanh Thu Huynh
Celine Thanh Thu Huynh
KBKelley M. Bastin
Kelley M. Bastin
BRBrianna N. Rivera
Brianna N. Rivera
LSLisbeth K. Siddens
Lisbeth K. Siddens
Susan C TiltonSusan C Tilton
Susan C Tilton